Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.

Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.

http://www.wikidata.org/entity/Q35706496

about

Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal Alzheimer's pathogenesis and its link to the mitochondrion Mitochondrial dysfunction in neurodegenerative diseases Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease.Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice.Microglial Inhibitory Mechanism of Coenzyme Q10 Against Aβ (1-42) Induced Cognitive Dysfunctions: Possible Behavioral, Biochemical, Cellular, and Histopathological Alterations.Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo Coenzyme Q10 effects in neurodegenerative disease.Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease Folic Acid and coenzyme q10 ameliorate cognitive dysfunction in the rats with intracerebroventricular injection of streptozotocin.Biochemistry of Mitochondrial Coenzyme Q Biosynthesis.

P2860

Q26783344-E7D69CC8-1C42-45C5-A625-7C02815A7154 Q27000255-A1E758E4-CD10-414A-B19E-13068D62F0E2 Q28387647-C31FC71C-B859-4BD1-8255-A7BD3991D1EA Q33625254-D7A4B6D3-1BEB-41F6-833F-C17CD20DB0AE Q33837238-7F12C17B-083C-4F3D-8374-C2D83FC48FE0 Q34309756-847B10CC-2A91-4FB2-80B1-183E6F352B88 Q34575595-11A80F0B-F88C-4335-B352-CC1CE0348A19 Q35756089-A858BA2F-3B92-4FE4-91EA-B5C547A4D5AB Q36260932-13822490-41BE-4552-85F6-691E87D856DF Q36271462-71FB4BBF-5B7B-47AB-8B29-5121E5B62D8C Q37448888-2A667A58-F2C4-49B4-9B65-A1FDDC039292 Q37741560-BDB39216-9893-4D83-BA84-D16506AAABA3 Q42231682-E9A6B4E3-4467-49A9-9D25-D7E7FF92DF10 Q47777099-E9BC1672-0CFF-41C7-9F1D-F0941B394807

P2860

Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.

http://www.wikidata.org/entity/Q35706496

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Coenzyme Q10 decreases amyloid ...... model of Alzheimer's disease.

@ast

Coenzyme Q10 decreases amyloid ...... model of Alzheimer's disease.

@en

type

label

Coenzyme Q10 decreases amyloid ...... model of Alzheimer's disease.

@ast

Coenzyme Q10 decreases amyloid ...... model of Alzheimer's disease.

@en

prefLabel

Coenzyme Q10 decreases amyloid ...... model of Alzheimer's disease.

@ast

Coenzyme Q10 decreases amyloid ...... model of Alzheimer's disease.

@en

P1433

Q35706496-5635C09D-97B1-4E34-8E59-8D73D45683E6

P1476

Q35706496-B6999CEF-F6F1-4AC6-B98B-9066FFF2A039

P2093

Q35706496-16928640-12A9-4A92-B1C7-2CAD07AA1573

Q35706496-353AFF76-0AB1-4A09-AD15-88BBB5605A72

Q35706496-37E4A683-7594-4ADD-BB33-0CBA76EDCB14

Q35706496-391CDCB5-52A2-4BB1-B328-5C24EF7FE924

Q35706496-5FA48DFE-C75A-4E0A-BD6A-35ACE8E065F2

Q35706496-82F9CA43-0480-4452-A573-7BF18FB3F912

Q35706496-A01A913E-49ED-4B79-A982-BA514190B664

Q35706496-BD932BBD-4EB1-4C4E-B54C-50E31A7D1136

P2860

Q35706496-046E3802-0DDC-415F-9904-378DDA87661A

Q35706496-054E850E-6678-4E2F-9FAB-715F46BC0C9E

Q35706496-08A32C3F-8A7E-4A86-8F6B-F171CF0A0009

Q35706496-0ADEEFA0-10EF-492C-A3C4-5AAE3A20F856

Q35706496-0E85A84C-CE8D-4B0F-B4C8-BEFDEA70789C

Q35706496-0EA7FB7D-5A64-4FED-9724-AE5AA5EA4B34

Q35706496-10C71CEB-8D40-4FCE-BE65-CC43F7C0BA6F

Q35706496-1674128D-1531-4477-A922-B462D5BCFE96

Q35706496-1920E9D7-2DBB-4CC8-BBB0-621C32F55BF1

Q35706496-21DB3FBD-51D3-4D4A-9BE5-328FFB0BBF26

P304

Q35706496-E71D0CBB-F279-4DE4-8868-F35CEF63B827

P31

Q35706496-AC3FFBF9-4BAA-46DA-AD70-CFCBD8346897

P356

Q35706496-C7A2BC4F-B640-48A3-A739-2FDBF79D37C5

P433

Q35706496-58DD0E42-DD14-4BBA-89E3-93C619C42812

P478

Q35706496-301E5968-06F4-4B64-8011-336C1E381E51

P50

Q35706496-3FC57B8D-656F-443E-8E18-A4710A160531

P577

Q35706496-2D44550B-A6C9-4E0E-BF46-180948B5A09E

P698

Q35706496-7CB086D4-5463-47FF-BD97-A58C58294BF9

P921

Q35706496-3853DEE5-F415-447F-9CB1-AA5C8A168858

Q35706496-9B316CBE-62E1-4E55-A5F7-0CF89501CDD1

P932

Q35706496-7DBC9237-9BCC-41D0-9D10-09D856D9E1D3

P356

JAD-2011-110209

P1433

Journal of Alzheimer's Disease

P1476

Coenzyme Q10 decreases amyloid ...... model of Alzheimer's disease.

@en

P2093

Elizabeth Wille

http://www.w3.org/2001/XMLSchema#string

Fangmin Yu

http://www.w3.org/2001/XMLSchema#string

Khatuna Kipiani

http://www.w3.org/2001/XMLSchema#string

M Flint Beal

http://www.w3.org/2001/XMLSchema#string

Magali Dumont

http://www.w3.org/2001/XMLSchema#string

Maya Katz

http://www.w3.org/2001/XMLSchema#string

Michael T Lin

http://www.w3.org/2001/XMLSchema#string

Noel Y Calingasan

http://www.w3.org/2001/XMLSchema#string

P2860

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

Regulation of NMDA receptor trafficking by amyloid-beta

Mitochondrial free radical generation, oxidative stress, and aging

APP processing and synaptic function

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.

Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease.

Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations

P304

211-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2011-110209

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Gunnar K. Gouras

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21799249

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3267988

http://www.w3.org/2001/XMLSchema#string